BOM Brabant Ventures

BOM Brabant Ventures is an incubator and growth accelerator with over 35 years of experience, dedicated to supporting ambitious companies in the Brabant region. The organization provides knowledge and risk capital to facilitate the growth of startups and scaleups, focusing on key industries such as High Tech Systems and Materials, Agrofood, Biobased Economy, Life Sciences and Medtech, Maintenance, and Supply Chain. Through its expertise, BOM Brabant Ventures aims to foster sustainable development and innovation within these sectors, ensuring the long-term success of its portfolio companies.

Sjoerd Coolen

Investor

23 past transactions

SamanTree Medical

Series B in 2024
SamanTree Medical SA is a Swiss medical microscopy device company specializing in advanced micro-optics based digital microscopy systems designed for research, diagnostic, and surgical applications. Founded in 2014 and located in Ecublens, Switzerland, the company focuses on enhancing cancer treatment through innovative imaging solutions. Its flagship product is a surgical digital microscope that enables real-time visualization of the cellular structure of living tissue, allowing surgeons to accurately assess tumor margins during procedures. This technology facilitates improved surgical treatment decisions, enhances resection accuracy, and helps reduce re-operation rates, ultimately lowering the overall costs associated with surgical interventions. By providing histology-grade confidence and full margin control during lumpectomies, SamanTree Medical aims to significantly improve patient care and outcomes in cancer surgery.

Microsure

Series B in 2023
Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in the development of innovative solutions for microsurgery, focusing on enhancing surgical performance through its motion stabilizer system. This device assists microsurgeons by scaling down motion and filtering out tremors, thereby providing extraordinary control and precision during procedures. The system aims to improve the quality of microsurgical operations, enabling the exploration of new and highly accurate surgical techniques that were previously unavailable. Microsure's technology has been successfully tested in clinical trials, demonstrating its effectiveness in lymphedema surgeries. By facilitating the use of surgeons' own micro-instruments, the device also aims to reduce costs for healthcare facilities while increasing the number of treatment options available for patients.

Sirius Medical

Series B in 2023
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

Scailable

Seed Round in 2022
Scailable is a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions efficiently. The company provides a robust platform that enables the deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices. Scailable's technology integrates seamlessly into continuous delivery pipelines, allowing developers to establish their own AI model management interfaces. This approach facilitates secure and modular access to AI services, ensuring functionality even on devices with minimal memory. By streamlining the deployment process, Scailable empowers clients to leverage AI capabilities effectively while maintaining control over their applications.

STENTiT

Seed Round in 2022
STENTiT is a medical device company that originated as a spin-off from the Eindhoven University of Technology in the Netherlands. The company specializes in the development of regenerative endovascular implants, specifically biodegradable stents designed to restore arteries. STENTiT's innovative products aim to trigger a natural healing response in patients, allowing blood cells to replace the implant with new vascular tissue. This approach enables medical professionals to effectively treat patients suffering from cardiovascular diseases by promoting internal restoration of the affected arteries.

Sirius Medical

Series A in 2021
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

Ctrlchain

Seed Round in 2021
CtrlChain focuses on simplifying and automating logistics management to enhance profitability, visibility, and service levels for shippers and carriers. The company provides streamlined, centralized systems for managing freight, which reduce manual operations and costs while offering data-driven insights to optimize transport operations. CtrlChain's online logistics software is designed to handle both regular and urgent shipments sustainably, featuring live tracking, order history, easy booking, and instant availability for courier requests. By making optimal use of existing transport capacity, the company ensures timely and safe delivery of packages and couriers for businesses and other clients.

Scailable

Pre Seed Round in 2021
Scailable is a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions efficiently. The company provides a robust platform that enables the deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices. Scailable's technology integrates seamlessly into continuous delivery pipelines, allowing developers to establish their own AI model management interfaces. This approach facilitates secure and modular access to AI services, ensuring functionality even on devices with minimal memory. By streamlining the deployment process, Scailable empowers clients to leverage AI capabilities effectively while maintaining control over their applications.

Orbisk

Seed Round in 2021
Orbisk is a developer of fully automated food waste monitoring equipment aimed at enhancing sustainability within the food service industry. The company's innovative solution includes a smart camera equipped with an artificial intelligence image recognition algorithm that identifies food ingredients from images. By integrating this technology into waste bins, Orbisk enables hospitality organizations to gain comprehensive insights into their food waste, quantifying large volumes of discarded food. This data-driven approach allows restaurants to identify inefficiencies in their food-providing processes, facilitating significant reductions in food waste and contributing to improved sustainability and profitability.

Trabotyx

Seed Round in 2021
Trabotyx specializes in agricultural robotics, developing a platform of autonomous single-row weeding robots. Their adaptable wheelbase accommodates diverse field layouts, targeting weeds within 5 centimeters to 1 centimeter of plants, reducing manual labor demands for organic farmers while enhancing biodiversity and soil health.

Microsure

Series B in 2021
Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in the development of innovative solutions for microsurgery, focusing on enhancing surgical performance through its motion stabilizer system. This device assists microsurgeons by scaling down motion and filtering out tremors, thereby providing extraordinary control and precision during procedures. The system aims to improve the quality of microsurgical operations, enabling the exploration of new and highly accurate surgical techniques that were previously unavailable. Microsure's technology has been successfully tested in clinical trials, demonstrating its effectiveness in lymphedema surgeries. By facilitating the use of surgeons' own micro-instruments, the device also aims to reduce costs for healthcare facilities while increasing the number of treatment options available for patients.

Shypple

Series A in 2021
Shypple is a digital freight forwarder that specializes in optimizing global supply chains through advanced technology. The company is comprised of a team with extensive backgrounds in logistics, international trade, and forwarding, which drives their mission to streamline the process of booking, managing, and tracking freight shipments. Shypple's platform features a digital dashboard that serves as a central hub for information, enhancing collaboration among all stakeholders in the logistics process. By offering routing options, price comparisons from various carriers, and real-time shipment visibility, Shypple aims to improve accountability and efficiency in international trade while maintaining the personal service expected from traditional forwarders. This approach allows enterprises to navigate the complexities of global freight movement with greater ease and transparency.

Orbisk

Pre Seed Round in 2020
Orbisk is a developer of fully automated food waste monitoring equipment aimed at enhancing sustainability within the food service industry. The company's innovative solution includes a smart camera equipped with an artificial intelligence image recognition algorithm that identifies food ingredients from images. By integrating this technology into waste bins, Orbisk enables hospitality organizations to gain comprehensive insights into their food waste, quantifying large volumes of discarded food. This data-driven approach allows restaurants to identify inefficiencies in their food-providing processes, facilitating significant reductions in food waste and contributing to improved sustainability and profitability.

Xyall

Series A in 2020
Xyall is a global innovator in the field of molecular pathology, specializing in advanced tissue dissection technology. The company has developed a platform that automates and digitizes the tissue dissection workflow, enhancing accuracy and efficiency in molecular diagnostics. This technology not only scales with demand but also reduces operational costs and minimizes the risk of cross-contamination. Additionally, it ensures traceability for each sample and test, allowing pathologists to obtain reliable diagnostic results in real-time. Through its innovative solutions, Xyall aims to improve the quality and reliability of molecular pathology services.

Knowingo+

Seed Round in 2019
Knowingo provides live data and statistics on employees’ knowledge levels across different topics.

Citryll

Series A in 2019
Citryll is a private pharmaceutical company based in Oss, The Netherlands, established in 2015. The company specializes in the development of pharmaceutical drugs aimed at treating autoimmune and other human diseases. Citryll's innovative approach focuses on the formation, function, and clearance of neutrophil extracellular traps (NETs) that are associated with the protein citrullination pathway, which is catalyzed by Peptidylarginine Deiminase (PAD) enzymes. This research and development are instrumental in providing treatment options for various conditions, including lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis, and organ damage resulting from sepsis.

DENS

Seed Round in 2019
Dutch Energy Systems focuses on innovative hydrazine solutions that enable the generation of hydrogen and electricity for enterprises operating independently of the power grid. The company manufactures a power generator that converts hydrazine into hydrogen, subsequently producing electricity. This technology offers a renewable and zero-emission alternative to traditional diesel-powered generators, providing clients with a sustainable and silent power source. DENS solutions are particularly beneficial in reducing emissions from heavy-duty vehicles and machinery across various sectors, including agriculture and construction, which typically rely on diesel fuel. By promoting cleaner energy alternatives, Dutch Energy Systems aims to contribute significantly to environmental sustainability.

SamanTree Medical

Series A in 2019
SamanTree Medical SA is a Swiss medical microscopy device company specializing in advanced micro-optics based digital microscopy systems designed for research, diagnostic, and surgical applications. Founded in 2014 and located in Ecublens, Switzerland, the company focuses on enhancing cancer treatment through innovative imaging solutions. Its flagship product is a surgical digital microscope that enables real-time visualization of the cellular structure of living tissue, allowing surgeons to accurately assess tumor margins during procedures. This technology facilitates improved surgical treatment decisions, enhances resection accuracy, and helps reduce re-operation rates, ultimately lowering the overall costs associated with surgical interventions. By providing histology-grade confidence and full margin control during lumpectomies, SamanTree Medical aims to significantly improve patient care and outcomes in cancer surgery.

CytoSMART Technologies

Series B in 2019
CytoSMART Technologies, founded in 2012 and based in the Netherlands, specializes in the development and manufacturing of innovative devices for cell culture monitoring and counting. The company's product lineup includes the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which integrate advanced technology with custom software to improve the efficiency of cell culture processes. These devices enable researchers to monitor cell growth remotely, reducing the need for constant laboratory presence. CytoSMART's clientele includes prestigious institutions and organizations such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews, highlighting its commitment to enhancing research capabilities in laboratories worldwide.

Enpicom

Series A in 2019
Enpicom is a bioinformatics software company that specializes in supporting scientists in the biopharmaceutical and academic research sectors. The company offers innovative products and customized solutions aimed at improving and accelerating the discovery and development of novel immunotherapies and vaccines. Enpicom's technology-agnostic and code-free software simplifies the management and analysis of immune repertoire sequencing data, thereby streamlining the antibody discovery process. This enables researchers to concentrate on their scientific inquiries and advancements, ultimately contributing to improved human health.

Additive Industries

Debt Financing in 2019
Additive Industries B.V., founded in 2012 and headquartered in Eindhoven, Netherlands, specializes in the design and manufacture of industrial metal additive manufacturing systems. The company aims to transition metal additive manufacturing from laboratory environments to industrial applications by providing a modular 3D printing system and an integrated information platform. This technology enhances reproducibility, productivity, and flexibility, redefining the business case for additive manufacturing in sectors such as aerospace, automotive, medical technology, and high-tech equipment. Additive Industries focuses on producing lighter, compact, and complex parts with superior thermal performance, enabling its clients to operate more efficiently within their production processes. The company's team consists of highly experienced engineers and professionals from the high-tech equipment sector, contributing to its innovative approach in the field of additive manufacturing.

DegenRx B.V.

Series A in 2018
DegenRx is a biotech startup working on AAV-mediated gene therapy for CNS disorders like Parkinson's and Alzheimer's. They transmit genes to the brain that start the local synthesis of therapeutic antibodies using adeno-associated-viral vectors. Its goal is to discover and create treatments for neurodegenerative disorders so people can age longer and healthier.

CytoSMART Technologies

Series A in 2016
CytoSMART Technologies, founded in 2012 and based in the Netherlands, specializes in the development and manufacturing of innovative devices for cell culture monitoring and counting. The company's product lineup includes the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which integrate advanced technology with custom software to improve the efficiency of cell culture processes. These devices enable researchers to monitor cell growth remotely, reducing the need for constant laboratory presence. CytoSMART's clientele includes prestigious institutions and organizations such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews, highlighting its commitment to enhancing research capabilities in laboratories worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.